Inhye E. Ahn

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.518Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

Blood Advances(2024)10.1182/bloodadvances.2023011574

Top 37%

0.518DataRank

Top 37%12 citations

Danielle M. Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A. Walker +18 more

Papers

Driven by 23 papers — median percentile 63. Top paper: “Outcomes of COVID-19 in patients with CLL: a multicenter international experience”.

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Blood(2020)10.1182/blood.2020006965

N/A

13.4DataRank · unranked

318 citations

Lindsey E. Roeker, Nicole Lamanna, John N. Allan, Lori A. Leslie, John M. Pagel +57 more

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

Blood(2020)10.1182/blood.2020008758

N/A

7.9DataRank · unranked

141 citations

Mir A. Ali, Jeffrey I. Cohen, Xin Tian, Susan Soto, Inhye E. Ahn +9 more

COVID-19 in patients with CLL: improved survival outcomes and update on management strategies

Blood(2021)10.1182/blood.2021011841

N/A

3.5DataRank · unranked

70 citations

Toby A. Eyre, Meghan C. Thompson, Nicole Lamanna, Alexander Coltoff, Matthew S. Davids +47 more

Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib

Blood(2020)10.1182/blood.2019003715

N/A

3.3DataRank · unranked

106 citations

Pia Nierman, Ellen K. Kendall, Jean Cheung, Michael Gulrajani, Sarah E. M. Herman +16 more

Long‐term efficacy of first‐line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials

British Journal of Haematology(2021)10.1111/bjh.17984

N/A

2.2DataRank · unranked

64 citations

Tait D. Shanafelt, Adrian Wiestner, Carol Moreno, Susan O’Brien, Jianling Li +4 more

Clinical Outcomes in Patients with Multi-Hit TP53 Chronic Lymphocytic Leukemia Treated with Ibrutinib

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4890

N/A

1.5DataRank · unranked

40 citations

Kathrine Aarup, Mathias H. Torp, Michael Asger Andersen, Christina W. Yde, Xin Tian +4 more

CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3217

N/A

0.782DataRank · unranked

21 citations

Jonathan Chen, Erika M. Gaglione, Chingiz Underbayev, Pamela L. Tuma, Xin Tian +12 more

Overcoming Acquired Epigenetic Resistance to BTK Inhibitors

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0063

N/A

0.619DataRank · unranked

61 citations

James D. Phelan, James Q. Wang, Dawei Huang, George W. Wright, Monica Kasbekar +26 more

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

Blood Advances(2024)10.1182/bloodadvances.2023011574

Top 37%

0.518DataRank

Top 37%12 citations

Danielle M. Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A. Walker +18 more

BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL

Blood Advances(2022)10.1182/bloodadvances.2021006574

N/A

0.510DataRank · unranked

29 citations

Kerry J. Laing, Mir A. Ali, Christopher L. McClurkan, Susan Soto, Inhye E. Ahn +10 more

B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3887

N/A

0.434DataRank · unranked

17 citations

Paolo Ghia, John C. Byrd, Inhye E. Ahn, Carol Moreno, Susan O’Brien +8 more

Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025016006

N/A

0.385DataRank · unranked

12 citations

Yinglu Zhou, Mariia Mikhaleva, Daniel Choi, Stacey M. Fernandes, Philippe Armand +20 more

Select Antitumor Cytotoxic CD8+ T Clonotypes Expand in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4894

N/A

0.385DataRank · unranked

12 citations

Sivasubramanian Baskar, Erika M. Gaglione, Keyvan Keyvanfar, Inhye E. Ahn, Adrian Wiestner +2 more

Therapeutic targeting of apoptosis in chronic lymphocytic leukemia

Seminars in Hematology(2024)10.1053/j.seminhematol.2024.01.015

N/A

0.312DataRank · unranked

7 citations

Matthew S. Davids, Inhye E. Ahn

Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1888379

N/A

0.286DataRank · unranked

4 citations

Clifton C. Mo, Erika M. Gaglione, Constance M. Yuan, Maryalice Stetler‐Stevenson, Xin Tian +20 more

State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee

Blood Cancer Journal(2025)10.1038/s41408-025-01341-6

N/A

0.219DataRank · unranked

3 citations

Inhye E. Ahn, Aswin Sekar, Andy C. Rawstron, Júlia Almeida, José Ignacio Martin-Subero +18 more

SAVE (Safe Accelerated Venetoclax Escalation): Initial results of a prospective, phase Ib study of venetoclax with an accelerated dose ramp-up in patients with CLL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7512

N/A

0.165DataRank · unranked

2 citations

Inhye E. Ahn, Svitlana Tyekucheva, Reid W. Merryman, David C. Fisher, Philippe Armand +7 more

Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations

New England Journal of Medicine(2020)10.1056/nejmc2005943

N/A

0DataRank · unranked

115 citations

Xin Tian, Adrian Wiestner, Inhye E. Ahn

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting

Blood Advances(2023)10.1182/bloodadvances.2022009517

N/A

0DataRank · unranked

40 citations

Erika M. Gaglione, David Eik, John H. Herrick, J. Le, Inhye E. Ahn +11 more

Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors

Leukemia & lymphoma/Leukemia and lymphoma(2020)10.1080/10428194.2020.1772477

N/A

0DataRank · unranked

27 citations

Clare Sun, Sanjal H. Desai, Inhye E. Ahn, Xin Tian, Pia Nierman +6 more

Concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and hairy cell leukemia: clinical, pathologic and molecular features

Leukemia & lymphoma/Leukemia and lymphoma(2020)10.1080/10428194.2020.1797007

N/A

0DataRank · unranked

11 citations

Ivo M.B. Francischetti, Hao‐Wei Wang, Inhye E. Ahn, Weixin Wang, Mark Raffeld +4 more

Sudden death and asymptomatic arrhythmia in chronic lymphocytic leukemia patients treated with ibrutinib

Heart Rhythm(2025)10.1016/j.hrthm.2025.10.014

N/A

0DataRank · unranked

0 citations

Andy Itsara, Mark C. Haigney, Douglas R. Rosing, Inhye E. Ahn, Cody Peer +7 more

A phase II study of ibrutinib and short‐course fludarabine in previously untreated patients with chronic lymphocytic leukemia

American Journal of Hematology(2020)10.1002/ajh.25968

N/A

0DataRank · unranked

5 citations

Xin Tian, Shakuntala Rampertaap, Rui Mu, Susan Soto, Jeanine Superata +12 more

Inhye E. Ahn

Indexed papers

Top data-sharing exemplar

Papers